Researchers have identified compounds that appear to inhibit a signaling pathway in Huntington’s disease, a finding that may eventually lead to a potential drug therapy to help slow the progression of degenerative nerve disorders.
Researchers have identified compounds that appear to inhibit a signaling pathway in Huntington’s disease, a finding that may eventually lead to a potential drug therapy to help slow the progression of degenerative nerve disorders.